ArticleNeuroinformatics2026
Quantifying Structural Changes in Cultured Neurons Using Fractal Analysis.
Article in Neuroinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative analysis of neuronal morphology in dense cultures remains technically challenging, as extensive overlap between neuritic arbors and background signal limits the applicability of traditional tracing-based approaches. Here, we applied fractal dimension (FD) and lacunarity (LAC) analysis as scale-invariant, global measures of neurite complexity and systematically compared them with classical morphometric approaches in dense primary hippocampal neuronal cultures. Neurons were treated with the Abl tyrosine kinase inhibitor imatinib to induce cytoskeletal remodeling. Fractal analysis was performed on skeletonized representations derived from standardized binarized confocal images, enabling robust quantification of neurite space-filling properties across spatial scales. Imatinib treatment induced a pronounced reduction in FD (DMSO: ~1.56 ± 0.04 vs. IMA: ~1.36 ± 0.05, p < 0.001) together with increased lacunarity, indicating reduced multiscale complexity and increased spatial heterogeneity. In contrast, classical morphometric analysis revealed a heterogeneous phenotype, with elongation of primary neurites accompanied by reduced branching. These opposing effects partially compensated for one another, obscuring overall complexity changes when assessed using individual parameters. To integrate multivariate features, we constructed a composite Neurite Complexity Index (NCI) incorporating branching, neurite length, and distribution-sensitive descriptors (R² ≈ 0.98; F(4,106) = 89.6, p < 1 × 10⁻
Indexed as
Identifiers
42440205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.